Bimekizumab Maintained Efficacy Responses in Patients with Active Psoriatic Arthritis: Up to 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Walsh, Jessica A. [1 ,2 ]
Merola, Joseph F. [3 ]
Ritchlin, Christopher T. [4 ]
Tanaka, Yoshiya [5 ]
Favalli, Ennio Giulio [6 ]
McGonagle, Dennis [7 ]
Thaci, Diamant [8 ]
Ink, Barbara [9 ]
Bajracharya, Rajan [9 ]
Coarse, Jason [10 ]
Tillett, William [11 ,12 ]
机构：
[1] Salt Lake City Vet Affairs Hlth, Div Rheumatol, Salt Lake City, UT USA
[2] Univ Utah Hlth, Salt Lake City, UT USA
[3] UT Southwestern Med Ctr, Dallas, TX USA
[4] Univ Rochester, Sch Med, Allergy Immunol & Rheumatol Div, Rochester, NY USA
[5] Univ Occupat & Environm Hlth, Dept Internal Med, Kitakyushu, Fukuoka, Japan
[6] ASST Gaetano Pini CTO, Milan, Lombardia, Italy
[7] Leeds Teaching Hosp, Leeds Biomed Res Ctr BRC, NIHR, Leeds, W Yorkshire, England
[8] Univ Lubeck, Inst & Comprehens Ctr Inflammat Med, Lubeck, Schleswig Holst, Germany
[9] UCB Pharma, Slough, Berks, England
[10] UCB Pharma, Morrisville, NC USA
[11] Royal Natl Hosp Rheumat Dis, Bath, Avon, England
[12] Univ Bath, Dept Life Sci, Ctr Therapeut Innovat, Bath, Avon, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0591
引用
收藏
页码：1206 / 1209
页数：4
相关论文
共 50 条
  • [21] Bimekizumab Safety and Efficacy in Patients with Psoriatic Arthritis: 3-Year Results from a Phase 2b Open-Label Extension Study
    Coates, L. C.
    Warren, R. B.
    Ritchlin, C. T.
    Gossec, L.
    Merola, J. F.
    Assudani, D.
    Coarse, J.
    Eells, J.
    Ink, B.
    McInnes, I. B.
    SWISS MEDICAL WEEKLY, 2021, 151 : S20 - S20
  • [22] EFFICACY AND SAFETY OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 737 - 738
  • [23] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study
    Kavanaugh, Arthur
    Puig, Luis
    Gottlieb, Alice B.
    Ritchlin, Christopher T.
    Li, Shu
    Wang, Yuhua
    Mendelsohn, Alan
    Song, Michael
    Rahman, Proton
    McInnes, Iain B.
    ARTHRITIS AND RHEUMATISM, 2013, 65 (12): : 3323 - 3324
  • [24] Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-year Results From a Phase 3, Multicenter, Double-blind, Placebo-controlled Study
    Kavanaugh, A.
    Puig, L.
    Gottlieb, A. B.
    Ritchlin, C.
    Li, S.
    Wang, Y.
    Mendelsohn, A. M.
    Song, M.
    Rahman, P.
    McInnes, I.
    SWISS MEDICAL WEEKLY, 2014, 144 : 8S - 9S
  • [25] Achieving Stringent Disease Control Criteria Was Associated with Greater Work Productivity Improvements in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Studies of Bimekizumab
    Tillett, William
    Gladman, Dafna
    Gossec, Laure
    Eells, Jason
    Healy, Patrick
    Ink, Barbara
    Lyris, Nikos
    Walsh, Jessica A.
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1196 - 1198
  • [26] SECUKINUMAB SUSTAINS INDIVIDUAL CLINICAL RESPONSES OVER TIME IN PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR RESULTS FROM A PHASE 3 TRIAL, FUTURE 2
    Emery, P.
    McInnes, I. B.
    Mease, P. J.
    Schiff, M.
    Pricop, L.
    Shen, S.
    Wang, Z.
    Gaillez, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1329 - 1329
  • [27] LONG-TERM SUSTAINED EFFICACY AND SAFETY OF BIMEKIZUMAB ACROSS THE FULL SPECTRUM OF AXIAL SPONDYLOARTHRITIS 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Baraliakos, X.
    Deodhar, A.
    van der Heijde, D.
    van den Bosch, F.
    Magrey, M.
    Maksymowych, W. P.
    Tomita, T.
    Xu, H.
    Massow, U.
    Fleurinck, C.
    Vaux, T.
    Prajapati, C.
    Shepherd-Smith, J.
    Marten, A.
    Gensler, L. S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 93 - 94
  • [28] Sustained Improvements with Bimekizumab in Patient-Reported Symptoms of Axial Spondyloarthritis: 2-Year Results from Two Phase 3 Studies
    Marzo-Ortega, Helena
    Mease, Philip
    Dougados, Maxime
    Dubreuil, Maureen
    Magrey, Marina
    Rudwaleit, Martin
    D'Agostino, Maria Antonietta
    de la Loge, Christine
    Massow, Ute
    Taieb, Vanessa
    Voiniciuc, Diana
    Deodhar, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1209 - 1213
  • [29] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Philip J. Mease
    Ana-Maria Orbai
    Oliver FitzGerald
    Mohamed Bedaiwi
    Rajiv Dona L. Fleishaker
    Pamela Mundayat
    Philip S. Young
    Arthritis Research & Therapy, 25
  • [30] Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies
    Mease, Philip J.
    Orbai, Ana-Maria
    FitzGerald, Oliver
    Bedaiwi, Mohamed
    Fleishaker, Dona L.
    Mundayat, Rajiv
    Young, Pamela S.
    Helliwell, Philip
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
12345